Marissa C van Maaren

13PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesWomen's studies (incl. girls' studies)Formal methods for software
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 05, 2026
Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study.

|Apr 01, 2025
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study.

Ester P Olthof, Hans H B Wenzel, Marissa C van Maaren

|Oct 04, 2023
Gene expression profiles in clinically T1-2N0 ER+HER2- breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed.

L M van Roozendaal, M L G Vane, E Colier

|Dec 22, 2020
Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.

Willemien J Kruik-Kollöffel, Job van der Palen, Carine J M Doggen

|Nov 30, 2020
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017.

Daniël J van der Meer, Iris Kramer, Marissa C van Maaren

|Nov 14, 2019
Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer.

Erik Heeg, Perla J Marang-van de Mheen, Marissa C Van Maaren

Pageof 3

Frequent Collaborators

2 joint publications

Luc J A Strobbe

2 joint publications

Sabine Siesling

2 joint publications

Sabine C Linn

2 joint publications

Paul J van Diest